Cholesteric Liquid Crystal Droplets for Biosensors - ACS Applied

Subscriber access provided by EPFL | Scientific Information and Libraries

Article

Cholesteric liquid crystal droplets for biosensors Hyun Gyu Lee, Sundas Munir, and Soo-Young Park ACS Appl. Mater. Interfaces, Just Accepted Manuscript • DOI: 10.1021/acsami.6b09624 • Publication Date (Web): 12 Sep 2016 Downloaded from http://pubs.acs.org on September 16, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

ACS Applied Materials & Interfaces is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Applied Materials & Interfaces

Cholesteric liquid crystal droplets for biosensors Hyun-Gyu Lee, Sundas Munir and Soo-Young Park* Department of Polymer Science & Engineering, Polymeric Nanomaterials Laboratory, School of Applied Chemical Engineering, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Korea *Corresponding author: [email protected] Abstract Using a microfluidic method, we prepared uniformly sized cholesteric liquid crystal (CLC) droplets from MLC2132 doped with (S)-4-cyano-4′-(2-methylbutyl)biphenyl (CB15). We studied the helical structures and reflecting color patterns of high- and low-dopant CLC droplets coated with poly(vinyl alcohol) (PVA) and sodium dodecyl sulfate (SDS). One central large spot with reflecting color in the CLC droplets (initially coated with PVA for planar anchoring) changed to many small spots with the same reflecting color (chicken-skin pattern) when an SDS aqueous solution was introduced to increase the homeotropic anchoring power. These small spots subsequently merged into several spots (flashlight pattern) with time. The CLC droplets coated with poly(acrylic acid)-b-poly(4-cyanobiphenyl-4′-oxyundecylacrylate) (PAA-b-LCP) (CLCPAA droplets) were pHresponsive. Their helical structure and the reflecting color pattern changed because of protonation (at low pH) and deprotonation (at high pH) of the carboxylic group of PAA, which causes the planar (tangential) and perpendicular (homeotropic) orientations, respectively. The CLCPAA droplets immobilized with glucose oxidase (GOx) and cholesterol oxidase (ChO) (CLCPAA-GOx and CLCPAA-ChO droplets, respectively), for glucose and cholesterol detection, exhibited high sensitivity (0.5 and 2.5 µM for the CLCPAA-GOx and CLCPAA-ChO droplets, respectively), good selectivity, and fast response (≤ 4 s). Further optimization will enhance their performance as biosensors. With this novel approach, detection is possible by observing the coloring pattern of CLC droplets, without the crossed polarizers that are necessary for nematic LC biosensor systems.

Key words: Cholesteric liquid crystal, droplet, microfluidics, enzyme, biosensor

ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Introduction Liquid crystalline materials are promising candidates for the sensing of biomaterials 1-12. Liquid crystal (LC) ordering is highly sensitive to molecular-level physical and chemical interactions at the LC interface, which lead to changes in optical appearance. This property allows events that occur at the nanoscale level to be observed using optical microscopy. Furthermore, it is possible to tailor LC-aqueous interfaces in ways that lead to changes in the orientational order of the LC upon external stimuli. For example, the orientational ordering transition of thin LC films in a transmission electron microscopy (TEM) grid can be triggered by enzymatic reactions and interactions with lipids 13-15, surfactants 1, 6, 16-17, proteins 18-20, DNA 3, 21-22, and viruses 10, 23 at the modified LC-aqueous interface. The nature and extent of these changes is influenced by the structure of the modifying material at the LC interface (e.g., surfactant tail length or head group structure) 18, 20 and the types of processes at the LC interface that disrupt or perturb the LC orientation (e.g., local pH change by an enzymatic reaction) 13-14, 24-31. This LC-based reporting via orientational change offers potential advantages over conventional techniques because it does not require complex instrumentation or labeling. Most previous research has focused on using nematic LC (NLC) to sense biomaterials at LC interfaces. Another important type of LC, the cholesteric liquid crystal (CLC), has been widely used in electro-optic materials in display devices and in other responsive materials. Beside linear anisotropy and birefringence (as in nematic LCs), chirality at the supramolecular level is present in the cholesteric phase, where the helical configuration of the molecular director is responsible for interesting properties, such as selective reflection. CLCs have the ability to reflect circular polarized light at a given wavelength because of the self-organizing molecular helices. These properties have also proven to be effective for constructing optical sensors. In these sensors, a responsive molecular trigger provides specificity that leads to an amplified material response, resulting in a change of the reflection band. The reflection band of a CLC can be tuned by stimuli, such as temperature and light 32-43. In comparison to an NLC, a CLC has additional helical organization along the orientation of the director. This organization is characterized by a helical pitch (p), which is the distance corresponding to a 360° rotation of the mesogens along the helix director. If the length of the pitch is of the same order of magnitude as the wavelength of visible light, then the cholesteric phase selectively reflects light and shows a color in the visible range. Moreover, the reflecting colors of CLC are dependent on the pitch length. The wavelength of the selective reflection can be defined as λ = np, where n is the mean refractive index of the LC 44-45. If the pitch p changes in response to environmental variations in the visible range, and consequently, color (or structure) changes are observable, then a CLC can be used as an optical detector of external stimuli. The CLC phase can occur either when the mesogen is chiral or when the director is twisted by doping NLC with a chiral dopant. The helical structure of the CLC is originated by the chirality of the LC molecules. However, an achiral nematic LC can form the helical structure by doping with a chiral dopant and the achiral LC doped with a non-LC chiral moiety can exhibit the helical structure. The helical structure itself is not necessary to be chiral. The chirality does not affect the reflecting color patterns which is only dependent on the amount of chiral dopant. The helical twisting power (HTP) of a dopant is defined as HTP = 1/(pc), where c is the concentration of the dopant. Doped CLC have many favorable properties compared to CLCs, consisting of chiral mesogens. One of the advantages of a doped CLC is the ease with which its pitch can be tuned by changing the contents of the dopant 46 Chiral dopants can be shape-persistent or -switchable in response to environmental changes. Photo- or heat-responsive sensors have been implemented using shape-switchable chiral dopants 36-37, 42. However, synthesis of shape-switchable chiral dopants is sometimes difficult and time-consuming. Lee et al. have reported a microfluidic-based approach for the controlled formation of photonic microcapsules. They made the CLC droplet with the elastomeric solid membrane using triple-emulsion drops as the template to maintain their planar alignment. However, they did not functionalize the surface of the microcapsule for biosensor applications 47. LC-based sensing platforms include transmission electron microscopy (TEM) grids 1-12, 15-17, glass capillaries 48, and droplets 13-14. Droplets have attracted much attention because the geometric confinements of the LC in micrometer-sized droplets exhibit varied configurations, which depend on how the LC orientation (e.g., parallel or perpendicular) at the LC interface influences the LC structure throughout the droplet 24. As the simplest example for CLC droplets, the director field with tangentially aligning conditions 49-51 exhibits the Frank-Pryce spherulitic texture with concentric rings. Another anchoring condition occurs when the mesogenic groups are perpendicular to the droplet surface. Unusual and unique structures causing conical flashlight and ring reflections have recently been reported for these droplets with perpendicular mesogen orientation at the LC interface 52. Recently, a microfluidic technique was used to overcome the size-polydispersity bottleneck in the fabrication of LC droplets, thereby according wider applications to advanced photonic devices. If the tangential anchoring on the surface of a CLC droplet could be changed to homeotropic (perpendicular) anchoring by


Page 2 of 17

Page 3 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


external stimuli, then CLC droplets could be used as LC biosensors. To produce stimuli-responsive CLC droplets with a shape-persistent dopant, the surfaces of the CLC droplets should be functionalized with stimuliresponsive materials. Microfluidic methods can produce mono-dispersed functionalized NLC droplets for biosensing by coating stimuli-responsive materials. Environmental changes such as pH variation, protein binding, and enzymatic catalysis can cause the functional groups on these NLC droplets to induce the anchoring orientation to change between parallel and perpendicular 13-14 53-54 The coating materials can be surfactants 18, polyelectrolytes 31, and pH-sensitive block copolymers 30,55. NLC droplets with parallel (planar; P) and perpendicular (homeotropic; H) anchoring configurations are called bipolar and radial droplets, respectively. Bipolar and radial NLC droplets are typically produced by coating their surfaces with poly(vinyl alcohol) (PVA) and sodium dodecyl sulfate (SDS), respectively 56. NLC droplets can also be functionalized with block copolymers of polyelectrolyte-b-SGLCPs (SGLCP: side group LC polymer), where the polyelectrolyte block is in a charged state and the SGLCP block anchors the LC at the LC-aqueous interface 30. Strong polyelectrolytes such as poly(sodium styrene sulfonate) (PSS) and quaternized poly(4-vinylpyridine) (QP4VP) induce the H configuration of NLC droplets regardless of pH; however, weak polyelectrolytes such as poly[(dimethylamino)ethyl methacrylate] (PDMAEDA) and poly(acrylic acid) (PAA) induce an H or P configuration of NLC droplets depending on the pH 27-28, 52, 57-58. Poly(acrylic acid)-b-poly(4-cyanobiphenyl-4′oxyundecylacrylate) (PAA-b-LCP) is a coating material that enables NLC droplets to change their configuration via protonation and deprotonation of the PAA carboxylic group 52. At the LC-aqueous interface, the charged state of high-pH PAA induces the H configuration through deprotonation, and the neutral state of low-pH PAA induces the P configuration through protonation. A convenient feature of PAA-b-LCP as a droplet-coating material is that it can couple to amino groups via an N-hydroxysuccinimide/1-ethyl-3-(3dimethylaminopropyl)carbodiimide (EDC/NHS) reaction. Several enzymes such as glucose oxidase (GOx), cholesterol oxidase (ChO), and urease have been coupled to the surfaces of PAA-decorated NLC droplets to detect glucose 14, cholesterol 15, and urea 13, respectively. Combining the versatility of PAA-b-LCP with the unique photonic structure of cholesteric LC droplets may enable biosensing without polarized light. In the present study, we produced uniformly sized CLC droplets, and functionalized them with PAAb-LCP (denoted CLCPAA droplets), using a microfluidics method. We observed the effects of the charge state of the CLC surface on the configuration of the CLCPAA droplets. A surface electric field, generated by the charge state of a polyelectrolyte, exerts a poorly understood influence on the internal bulk orientation of a decorated CLC droplet. To investigate this influence and its implications for practical biosensor development, we immobilized the enzymes glucose oxidase (GOx) and cholesterol oxidase (ChO) on CLCPAA droplets with high or low chiral dopant content, and observed the changes that occurred in their coloring patterns and helical structures in the presence of glucose or cholesterol.

Experimental Materials MLC-2132 (Merck, UK, nematic to isotropic transition temperature: 114.0°C), (S)-4-cyano-4´-(2methylbutyl)biphenyl (CB15) (Synthon, Germany), polyvinyl alcohol (PVA) (Yakuri, Japan), sodium dodecyl sulfate (SDS) (DC Chemical Co., Ltd. Korea), polysorbate 80 (Sigma–Aldrich), rhodamine 6G (Sigma–Aldrich), N-hydroxysuccinimide (NHS) (Sigma–Aldrich), N-(3-dimethylaminopropyl)-N´-ethylcarbodiimide (EDC·HCl) (Sigma–Aldrich), pH buffer solutions (Samchun©, Korea), glucose (Sigma–Aldrich), glucose oxidase (GOx, Sigma–Aldrich), cholesterol (Sigma–Aldrich), cholesterol oxidase (ChO, Sigma–Aldrich), galactose (Sigma– Aldrich), hemoglobin (Sigma–Aldrich), L-ascorbic acid (Sigma-Aldrich), and human serum (Sigma–Aldrich) were used as received. Using a previously reported method 30, we polymerized PAA-b-LCP. Supplementary information (Scheme S1) contains details on the synthesis of PAA-b-LCP. Preparation of CLC droplets using microfluidics Uniform CLC droplets were produced using PDMS-based microfluidic flow-focusing devices with MLC-2132



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

doped CB15. For the fabrication of the microfluidic flow-focusing devices, PDMS was prepared by mixing the pre-polymer and cross-linker thoroughly at the recommended ratio of 10:1 (w/w). This mixture was degassed for 40 min in a desiccator to remove the remaining air bubbles. The final mixture was poured onto a structured silicon wafer mold, cured inside an oven at 65°C for 4 h, and removed from the mold. This patterned piece of PDMS was bonded to a pre-cleaned glass microscope slide using a short oxygen plasma treatment (46 s duration, Femto Science Inc., Korea). Figure S1 shows a schematic diagram of the microchip, with the dimensions of the microfluidics channel. The width of the inlet channels, the orifice width and length, and the width and height of the outlet channel were 110, 40, 40, 160, and 40 µm, respectively, and the depth of the channels was 100 µm throughout. The channel walls and chip assembly were made hydrophilic by treatment with APTES (2 wt% in ethanol) at 20°C for 10 min, and a second treatment at 60°C for 16 min. The microfluidic chip was mounted under an inverted biological microscope (Samwon NSI-100, South Korea). The liquid samples were supplied to the microfluidic device through flexible plastic tubings (Norton, USA, I.D. 0.51 mm, O.D. 1.52 mm) attached to the Fluiwell (Fluigent, France) containing the liquids. Flow rates were controlled using a pneumatic microfluidic flow rate control system (MFCS-EZ, Flow-Rate Platform and Flow-Rate Control Module, Fluigent) capable of pumping three fluids at a specified velocity. By pumping nitrogen gas at a finely controlled rate into the Fluiwell, the MFCS-EZ unit was used to pressurize the Fluiwell such that fluids began to flow through the tubes and into the device. The formation of on-chip droplets was imaged using an STC-TC83USB-AS camera (SenTech, Japan) attached to the inverted microscope. The droplets were observed under a polarized optical microscope (POM) (ANA-006, Leitz, Germany) with crossed polarizers and a CCD camera (STC-TC83USB, Samwon, South Korea). The dispersed CLC droplets were slowly injected into the middle inlet, and a continuous aqueous phase containing PVA (1 wt%), SDS (1 wt%), or PAA-b-LCP (0.2 wt%) was injected into the other inlets in a direction perpendicular to that of the dispersed phase. The perpendicular phase streams met at a junction, and droplet formation took place when each stream crossed the neck of its channel. The resulting CLC droplets were extracted from the microchip and collected in a 25 × 25 × 3.5 mm3 storage reservoir, which was made by gluing a thin silicon rubber sheet onto the glass slide. GOx (or ChO)-immobilized LC double droplets The CLCPAA droplets, collected in a vial, were activated for 1 h with EDC·HCl: NHS (0.4 M: 0.1 M) in PBS buffer (pH 7.0). To obtain the GOx-immobilized CLC droplets (CLCPAA-GOx droplets), we prepared a mixture of GOx (19 µM) and the activated CLCPAA droplets. The immobilization reaction occurred in this mixture for 12 h at 20°C. Immobilization of GOx to PAA was confirmed using GOx labeled with rhodamine 6G (GOx-rhd), which was prepared as follows. To activate the carboxylic groups (-COOH) of GOx, this enzyme was dissolved (15.6 µM) in PBS buffer (pH 7.0) with 0.4 M EDC·HCl and 0.1 M NHS. This activation proceeded for 1 h. Next, rhodamine 6G (1 mg) was added to the solution, and the mixture was stirred for 12 h at 20 °C. We subsequently immobilized the GOx-rhd to the CLCPAA droplets using the same method that we had used to immobilize GOx to the CLCPAA droplets. After immobilization, the reacted solution was diluted with distilled water to remove the unreacted GOx-rhd, and the resulting CLCPAA-GOx-rhd droplets were examined using a fluorescent microscope. To prepare CLCPAA-ChO, we repeated the above steps to immobilize ChO on the CLCPAA droplets. Measurements The formation of CLC droplets on a chip was imaged using a high-speed digital video-recording camera (Motion BLIZT Cube4, Mikroton, Germany) with an inverted microscope (JSP-20T, Samwon, South Korea). GOx-rhd was examined using a UV-vis spectrometer (UV-2401PC, Shimadzu, Japan), and the presence of GOxrhd on the CLCPAA-GOx-rhd droplets was confirmed by fluorescence microscopy (E600POL, Nikon Eclipse, Japan). We acquired 1H nuclear magnetic resonance (NMR) spectra of PAA-b-LCP at 400 MHz (400 MHz, Bruker, Germany). The molecular weight was measured by gel permeation chromatography (GPC, Acme9000, Young Lin Instrument Co., Ltd).

Results and discussion


Page 4 of 17

Page 5 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Preparation of CLC droplets at low chiral dopant concentrations When the content of chiral dopant in a CLC droplet (φ) is low, the droplet helical structure can be visualized through an optical microscope. PVA decoration on the CLC droplet causes tangential anchoring of CLC against the droplet surface. Figure 1a shows bright-field images of a CLCPVA droplet with φ = 0.8, 1, 2, 5, and 10 wt% chiral dopant. Helical structures with concentric rings are present, and their pitches decrease as φ increases. When the helical twist axis in the CLC droplet has a radial orientation, the tangential orientation of the droplet surface matches the mesogen orientation, which is perpendicular to the helical twist axis. Thus, the PVA coating on the surface of the CLC droplet leads to concentric rings. The pitch (p) of the helix in the CLCPVA droplet is twice the distance between consecutive rings, due to n = - n, where n is the LC director. Figure S2 plots p as a function of 1/φ, with good linearity (r2 = 0.9914). The slope of this line is the inverse of the helical twisting power (HTP). Helical twisting power is a measure of the ability of the chiral dopant to twist the NLC defined by p = 1/(HTP[c]). The HTP is 7.08 (µm-1), which is similar to the previously reported value 59. An ionic surfactant, SDS, was used for homeotropic anchoring on the surfaces of the CLC droplets. A completely different CLC droplet structure is observed (Figure 1b) for droplets produced with 1 wt% SDS aqueous solution (CLCSDS droplets). The twist axis of the mesogenic groups is tangential in the homeotropic anchoring so that the direction of the twisting axis does not match the radial direction of the droplet. Thus, under this homeotropic anchoring condition on the CLC droplet surface, a symmetric concentric ring structure cannot be obtained. The CLCSDS droplet shows the surface and bulk orderings that cause the spiral lines and concentric rings in the image, respectively. The typical surface spiraling disclination, which was numerically predicted for short-pitch cholesterics in the case of droplets with perpendicular surface anchoring conditions, was observed in the CLCSDS droplets 60. The most striking difference between the bulk orientations of CLCPVA and CLCSDS droplets is the position of the center of the concentric rings. At all studied φs, this center shifts from the droplet center for the CLCPVA droplet to off-center for the CLCSDS droplet. The p of CLCSDS is almost the same as that of CLCPVA. When φ is low (0.8 and 1 wt%, Figure 1b, i and ii), the parallel layers connect to the curvature of the droplet surface and become similar to a series of nested cups. At φ = 2, 5, and 10 wt%, the cups become closed, giving rise to radial singularities. Figure S3 shows the bright-field transmittance-mode, transmission-mode with cross polarizers, and bright-field reflection-mode images of CLCPVA droplets at φ = 12, 14, 16, and 18 wt%. The CLC droplets at this range do not show both the helical structure (due to its short pitch) and the reflection color (because the reflected light is out of visible range). PVA and SDS are known to cause parallel and perpendicular anchoring on the CLC surface, respectively. Therefore, the PVA- and SDS-coated CLC droplets were tested to find the characteristic CLC configuration by parallel and perpendicular anchoring on the CLC surface, respectively13-14. Thus, the profound difference between the optical images of the CLCPVA droplets and those of the CLCSDS droplets could be used in sensor applications, if environmental changes could induce the LC orientation to change between parallel and perpendicular.

Figure 1. Bright-field transmittance mode images of (a) CLCPVA and (b) CLCSDS droplets with φ = (i) 0.8, (ii) 1, (iii) 2, (iv) 5, and (v) 10 wt% chiral dopant.

Preparation of cholesteric LC droplets at high chiral dopant concentrations



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 2a shows reflection mode bright-field images of CLCPVA droplets with φ = 30, 35, 40, 45, and 50 wt% chiral dopant, which were prepared using the same method as the CLCPVA droplets with low φs. The helical structure could not be observed because of the short pitch. However, the reflection mode bright field images show different colors at the center of the CLCPVA droplets, depending on the φ. These colors result from the periodic nature of the droplet superstructure. The wavelength of the color is directly proportional to the pitch (the length scale of one complete rotation of the director). For CLC mixtures, the spectral position of the reflection band gap is described as λb = np, meaning that the spectral position is governed by the average refractive index of the mixture (n) and the pitch length (p = 1/([c]×HTP)). The reflection wavelength could be varied by adjusting the chiral dopant concentration ([c]) through the equation λb = n/(HTP[c]). The observed colors of the CLCPVA droplets at φ = 30, 35, 40, 45, and 50 wt% chiral dopant were red, orange, yellow, bright blue, and blue, respectively. The λbs calculated from HTP and n (1.64 for MLC-2132) at φ = 30, 35, 40, 45, and 50 wt% were 779.8, 668.4, 584.8, 519.9, and 467.9 nm, respectively. These wavelengths are well matched with those of human-observed colors. At φ = 25 and 55 wt% chiral dopant, the central spot was not observed, because the wavelength was not in the range of the visible spectrum. In addition to the central spot, some additional radial lines and spots on the line connecting the two central spots were observed. The intensities and sizes of the additional spots are much weaker and smaller than those of the central spot. These additional spots and lines are attributed to lateral photonic cross-talk between the droplets 61-62.When the incident light strike at an angle of 45º is reflected parallel to the substrate, and is then reflected again by the neighboring micro droplets at an angle of 45º perpendicular to the substrate. This reflection at different angles results in photonic cross-communication. Figure 2c shows the POM images of the CLCPVA prepared at different concentrations of chiral dopant. The images thus obtained show a cross pattern and a series of concentric rings around a small cross pattern at the center. These cross patterns and concentric rings are typical evidence of a radially oriented helical axis and suggest a macroscopic isotropic helical geometry of the helical structures. Figure 2b shows the reflection mode bright-field images of the CLCSDS droplets at φ = 30, 35, 40, 45, and 50 wt% chiral dopant, which were prepared using the same method as that used to prepare droplets with low φ. The central spots observed on the CLCPVA droplets disappeared, and strong flashlight-like spots were observed at the periphery of the CLCSDS droplet. This result is similar to the reported localized conical reflection (flashlight type) 52 of the emulsion in water with surfactant, which led to the formation of spherulite-like CLC droplets induced by intermediate anchoring conditions (between 0° and 90°, parallel and perpendicular, respectively) at the LC-aqueous interface. Figure 2d shows the POM images of the CLCSDS prepared at different concentrations of the chiral dopant. A homeotropic orientation was observed, corresponding to the perpendicular alignment of the mesogen along the substrate. This perpendicular orientation of the mesogen molecule did not match with the tangent of the microsphere, which could lead to the irregular patterns observed on the surface of the droplet. In particular, the presence of several randomly positioned flashlight spots in Figure 2b suggests that the several conical domains causing flashlight reflections were generated by the perpendicular anchoring conditions, as shown in Figure S4.


Page 6 of 17

Page 7 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figure 2. (a, b) Bright-field reflection-mode and (c, d) POM (under crossed polarizers) images of (a, c) CLCPVA and (b, d) CLCSDS droplets at φ = (i) 30, (ii) 35, (iii) 40, (iv) 45, and (v) 50 wt%. Structural transition of CLC droplets from parallel to perpendicular anchoring We investigated the transient structures occurring during transitions from planar (tangential) to homeotropic (perpendicular) orientations in the CLC droplets. To observe the structural transition of a CLC droplet during its change from planar to homeotropic orientation, excess SDS solution (5 wt%) was added to the CLCPVA droplet reservoir. Movie SI 1 and Figure 3 show the structural transition of CLC droplets stabilized with PVA (1 wt%) at φ = 2 wt% chiral dopant (low concentration, Figure 3a) and 45 wt% chiral dopant (high concentration, Figure 3b). The CLCPVA droplet at φ = 2 wt% chiral dopant exhibited a clear helical structure before the SDS solution was added. This helical structure completely changed into a featureless droplet upon SDS addition. However, 10 s later, a texture resembling a series of nested cups emerged. This texture indicated that the CLC molecules were in an intermediate anchoring condition. The long axes of the CLC molecules were roughly perpendicular to the surface at the interfacial region, consistent with the result shown in Figure 1b. The CLCPVA droplets at φ = 45 wt% chiral dopant (high concentration) exhibited clear circular blue spots at their centers prior to the addition of SDS solution. These spots disappeared 8 s after the SDS solution was added. New small, weak spots with a chicken skin-like appearance emerged (Figure 3b, ii). These small spots may be attributable to the small conical domains. The number of spots decreased and their size increased with time, indicating that these domains were merging and growing. Thus, the chicken-skin and flashlight structures may be attributed to the weak and strong perpendicular anchoring conditions, respectively. More details about chicken-skin and flashlight structures are provided in Figure S5.



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 3. Structural transition of CLCPVA droplets to CLCSDS droplets (i) 0, (ii) 4, (iii) 10, (iv) 18, and (v) 30 s after the addition of an aqueous SDS solution (5 wt%) to mixtures containing CLCPVA droplets at (a) φ = 2 and (b) φ = 45 wt% chiral dopant.

pH-sensitive CLC droplets coated with PAA-b-LCP To apply CLC droplets to biosensing, their surfaces should be coated with a material that responds to the external stimuli of interest, and this response should change the CLC droplet configuration. We implemented this design by decorating the surfaces of CLC droplets with the weak polyelectrolyte-containing block copolymer PAA-b-LCP. We named the resulting droplets as CLCPAA droplets. PAA is a weak polyelectrolyte. At low pH, PAA is protonated, has a neutral charge state, and as a bulk material, it shrinks. At high pH, PAA is deprotonated, has a negative charge state, and as a bulk material, it swells. The charged state of PAA favors a homeotropic orientation 30. Figure 4a shows the bright-field images of CLCPAA droplets at φ = 2 wt% chiral dopant under crossed polarizers at different pH. The closed, concentrically layered structure at low pH (pH 5, 6, and 7) changed to several open, layered, and divided domains at high pH (pH 8 and 9). When φ was high (φ = 35 wt% chiral dopant, Figure 4b), a clear yellow spot was observed at low pH (pH 5 and 6). At high pH (pH 7, 8, and 9), this central spot disappeared, and several small spots emerged at apparently random locations. Small red spots emerged from the small broken domain containing the remains of the helical structure. This broken domain may have been orientated with the layers parallel to the surface, causing the small reflection at the direction perpendicular to the layers as shown in scheme 1. Thus, the helical structure of the CLCPAA droplet is pH-sensitive. This pH-sensitive structure provides the basis for sensing pH-perturbing target analytes.

Scheme 1. Schematic models of the CLC configurations at (a) low and (b, c) high pH


Page 8 of 17

Page 9 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figure 4. Bright-field images of CLCPAA droplets with (a) φ = 2 and (b) φ = 35 wt% chiral dopant, at pH 5 (i), 6 (ii), 7 (iii), 8 (iv), and 9 (v). Effect of temperature Figure 5 depicts the effect of temperature on the optical appearance of the CLCPAA droplets prepared at different concentrations of φ. The optical appearance of the CLC droplets was not affected by the change in the temperature from 25–45ºC. These results suggested that CLC droplets could be utilized for sensing purposes within a wide range of temperatures.

Figure 5. Bright-field reflection-mode images of CLCPAA droplets with φ = (a) 30, (b) 35, and (c) 40 wt%, at (i) 25, (ii) 30, (iii) 35, (iv) 40, and (v) 45ºC. Glucose and cholesterol biosensor GOx and ChO can be immobilized via an EDC-NHS coupling reaction. To confirm successful immobilization, GOx was labeled with rhodamine 6G. Figure S6 shows the UV-vis absorption spectra of GOx, GOx-rhd, and rhodamine 6G. After labeling with rhodamine 6G, the spectrum of GOx-rhd exhibited a characteristic rhodamine 6G peak at 520 nm, indicating that the label had been successfully attached. GOx-rhd was subsequently



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

immobilized on CLCPAA droplets via an additional EDC-NHS coupling reaction. The inset of Figure SI 6 shows the image obtained upon excitation of the rhodamine fluorophore at a wavelength of 365 nm. A clear green color was observed, indicating that immobilization of GOx occurred successfully on the surfaces of the CLCPAA droplets. The resulting CLC droplets were named as CLCPAA-GOx droplets. 35 and 40 wt% of chiral dopant concentrations were utilized for the sensing of glucose and cholesterol, respectively. These concentrations of chiral dopant exhibited two distinct red and green colors. Therefore, this strategy could be utilized for multiple sensing systems. Figure 6a shows bright-field images of the CLCPAA-GOx droplets (φ = 35 wt% chiral dopant) after adding glucose solutions at different concentrations (Cgs) at pH 7. The initial scattered red spots at low Cgs (0.1 and 0.2 µM) changed to a central spot at high Cgs (0.5 and 1 µM), indicating that the CLCPAA-Gox droplet is suitable for use as a glucose biosensor, with a detection sensitivity of ~ 0.5 µM.”This transition occurred because an enzymatic reaction produced gluconic acid as the glucose solution was introduced, which decreased the pH at the interface, which may be a reason leading to conversion to the planar configuration 14. One of other possible reason causing the configurational change of the CLC droplet might be the specific binding of glucose and cholesterol leading to the conformational disruption of immobilized PAA chains, although the more detailed understanding of the mechanism is required. To evaluate the potential for interference from other biomaterials in human blood, hemoglobin (100 µM), galactose (100 µM), L-ascorbic acid (100 µM), and cholesterol (100 µM) aqueous solutions were added to the mixture (Figure 6b). The initial scattered red spots did not change after these biomaterials were added. In particular, the non-response for galactose, which has a similar structure as glucose (the main difference between them is the orientation of the hydroxyl group at the carbon), indicates that the CLCPAA-GOx droplet responded specifically to glucose. Human serum, which contains 0.022– 0.078 mM glucose, was also tested with water dilution, as shown in Figure 6c. The initial small, scattered red spots of the CLCPAA-GOx droplet at low glucose concentrations (500 and 200 × dilutions) changed to a central spot at high glucose concentrations (100 and 10 × dilutions). The glucose solution at 100 and 10 × dilutions contains 0.5 and 5 µM of glucose, respectively, consistent with limit of glucose detection. Thus, the CLCPAA-GOx droplet can be used to sense glucose in a real human blood sample, up to a limit of 100 × dilution with water. The CLCPAA-ChO droplet was prepared similarly (see experimental section). Figure 6d shows bright-field images of CLCPAA-ChO droplets with φ = 40 wt% chiral dopant. The dopant was chosen to distinguish between CLCPAAGOx and CLCPAA-ChO droplets by their red or green color. We added cholesterol solutions of different concentrations (Ccs) at pH 7. The initial scattered green spots at low Ccs (0.625 and 1.25 µM) changed to a central spot at high Ccs (2.5 and 25 µM), indicating that the CLCPAA-ChO droplet is suitable for use as a cholesterol biosensor, with a detection sensitivity of 2.5 µM. This transition occurs because an enzymatic reaction produces protons and cholest-4-ene-3-one as the cholesterol solution is introduced. The produced protons decrease the pH at the interface, leading to conversion to the planar configuration 63. Sekretaryova et al. studied the mechanism of electrochemical cholesterol sensors in detail and showed that the enzymatic reaction is vigorous after it starts. Wei et al. reported that the enzymatic reaction between cholesterol and cholesterol oxidase leads towards the formation of cholest-4-ene-3-one (D4-cholestenon) and is able to generate H+ as shown in scheme 2, which could be detected by pH-sensitive LCs polymers.


Page 10 of 17

Page 11 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figure 6. Bright-field images of CLCPAA-GOx droplets (φ = 35 wt% chiral dopant) after injecting (a) glucose solutions at Cg = (i) 0.1, (ii) 0.2, (iii) 0.5, (iv) 1 µM; (b) (i) hemoglobin (100 µM), (ii) galactose (100 mM), (iii) acid (100 µM), and (iv) cholesterol (100 µM) solutions; (c) (i) 500 ×, (ii) 200 ×, (iii) 100 ×, and (iv) 10 × diluted human serum (original glucose concentration was approximately 40–140 mg/dL (0.022–0.078 mM); (d) bright-field images of the CLCPAA-ChO droplets (φ = 40 wt% chiral dopant) at pH 7 after adding the cholesterol solutions at Cc = (i) 0.625, (ii) 1.25, (iii) 2.5, and (iv) 25 µM. L-ascorbic

+ 2O2

HO

Cholesterol oxidase

+ 2O2 + 2H+

O

Scheme 2. Cholesterol oxidase enzymatic reaction To confirm that the change in CLC configuration was due to the enzymatic reaction of GOx and ChO 100 µM of glucose and cholesterol solutions was injected into the cells without immobilizing GOx and ChO under otherwise similar conditions. A change in CLC droplets configuration was not observed, indicating that the configuration change was due to an enzymatic reactions. The optical response of the CLCPAA-GOx/ChO was noted at low and high pH as shown in Figure S7. The planar and homeotropic orientations were observed at low (4–6) and high pH (7–9), respectively. These results are similar to the CLCPAA, indicating that the orientational transitions of CLCPAA-GOx and CLCPAA-ChO droplets are triggered by pH on the introduction of the specific analyte.



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Next, the stability of the CLCPAA-GOx droplet was tested. Figure 7a shows bright-field images of the CLCPAA-GOx droplet at pH 7 when injecting a 100 µM glucose solution various days after the CLCPAA-GOx droplets were freshly prepared. The scattered spots of the CLCPAA-GOx droplet changed to the central spot immediately after 100 µM glucose solution was introduced (Figure 7a [i]). This structural change happened 10 d after the CLCPAAGOx droplets were prepared (Figures 7a [i] to [vi]). However, the scattered spots of the CLCPAA-GOx droplet did not change 10 d after the samples were freshly prepared (Figure 7a [vii] and [viii]), indicating that the CLCPAAGOx droplet is stable at least for 10 d. Next, the speed of glucose detection by the CLCPAA-GOx droplet was tested. Figure 7b shows bright-field images of the CLCPAA-GOx droplet at pH 7 at different time points after injecting 100 µM glucose solution. The scattered spots of the CLCPAA-GOx droplet (Figure 7b [i]) changed to the central spot 4 s after 100 µM glucose solution was introduced (Figure 7b [ii]), indicating that the CLCPAA-GOx droplet could detect glucose quite rapidly (within 4 s). Similarly, Figure 7c shows bright-field images of the CLCPAA-ChO droplet at pH 7 at different times after injecting 100 µM cholesterol solution. The scattered spots of the CLCPAAChO droplet (Figure 6c [i]) changed to the central spot 4 s after 100 µM cholesterol solution was introduced (Figure 7c [ii]), indicating that the CLCPAA-ChO droplet could detect cholesterol with a very short response time (within 4 s). Thus, the speed of the CLCPAA-GOx and CLCPAA-ChO droplets is sufficient for biosensor applications. In order to test the reproducibility and accuracy of the sensor, the CLCPAA-GOx and CLCPAA-Cho droplets were alternatively exposed to glucose and cholesterol solution followed by subsequent washing with ~ 10 mL of each PBS buffer (pH=7) and DI water to re-obtain the reference homeotropic state (data not shown). It was able to detect the glucose and cholesterol sample again. These results indicate that the CLCPAA-GOx and CLCPAA-Cho droplets can be used for multiple detections of glucose and cholesterol. Thus, the CLC droplets show high stability and activity, and capability of multiple usages through the covalent immobilization of the enzymes (GOx/ChO).


Page 12 of 17

Page 13 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figure 7. Bright-field images of the CLCPAA-GOx droplet (φ = 35 wt% chiral dopant) at pH 7 (a) when injecting 100 µM glucose solution (i) 0, (ii) 2, (iii) 4, (iv) 6, (v) 8, (vi) 10, (vii) 12, and (viii) 14 d after the CLCPAA-GOx droplets were freshly prepared, (b) (i) 0 (before), (ii) 4, (iii) 8, and (iv) 12 s after injecting 100 µM glucose solution, and the CLCPAA-ChO droplet (φ = 40 wt% chiral dopant) at pH 7 (C) (i) 0 (before), (ii) 4, (iii) 8, and (iv) 12 s after injecting 100 µM cholesterol solution. Conclusion A central reflecting spot, many chicken-skin-like spots, and several flashlight-like spots of the CLC droplet with high φs represented planar (tangential), weak, and strong homeotropic anchoring conditions on the droplet surface, respectively. The pH-responsive and color-inducing CLCPAA droplets at high φs were used as a basic platform for developing new biosensors by immobilizing enzymes on the surface. The CLCPAA-GOx and CLCPAAChO droplets showed high sensitivity, good selectivity, and fast response to the presence of glucose and cholesterol. This detection method is novel because changes in the color pattern are observable with the naked eye, without crossed polarizers needed in NLC systems. Acknowledgment: This study was supported by the National Research Foundation of Korea (NRF-20110020264 and NRF-2014R1A2A1A11050451).



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

References 1. Brake, J. M.; Daschner, M. K.; Luk, Y. Y.; Abbott, N. L., Biomolecular Interactions at PhospholipidDecorated Surfaces of Liquid Crystals. Science 2003, 302 (5653), 2094-2097. 2. Cadwell, K. D.; Lockwood, N. A.; Nellis, B. A.; Alf, M. E.; Willis, C. R.; Abbott, N. L., Detection of Organophosphorous Nerve Agents using Liquid Crystals Supported on Chemically Functionalized Surfaces. Sens. Actuator, B, 2007, 128 (1), 91-98. 3. Clare, B. H.; Abbott, N. L., Orientations of Nematic Liquid Crystals on Surfaces Presenting Controlled Densities of Peptides: Amplification of Protein-Peptide Binding Events. Langmuir 2005, 21 (14), 6451-6461. 4. Clare, B. H.; Efimenko, K.; Fischer, D. A.; Genzer, J.; Abbott, N. L., Orientations of Liquid Crystals in Contact with Surfaces that Present Continuous Gradients of Chemical Functionality. Chem. Mater. 2006, 18 (9), 2357-2363. 5. Goodby, J. W.; Saez, I. M.; Cowling, S. J.; Gortz, V.; Draper, M.; Hall, A. W.; Sia, S.; Cosquer, G.; Lee, S. E.; Raynes, E. P., Transmission and Amplification of Information and Properties in Nanostructured Liquid Crystals. Angew. Chem., Int. Ed. Engl. 2008, 47 (15), 2754-2787. 6. Gupta, J. K.; Meli, M. V.; Teren, S.; Abbott, N. L., Elastic Energy-Driven Phase Separation of Phospholipid Monolayers at the Nematic Liquid-Crystal-Aqueous Interface. Phys. Rev. Lett. 2008, 100 (4) 48301-48305. 7. Gupta, V. K.; Skaife, J. J.; Dubrovsky, T. B.; Abbott, N. L., Optical Amplification of Ligand-Receptor Binding using Liquid Crystals. Science 1998, 279 (5359), 2077-2080. 8. Jang, C. H.; Cheng, L. L.; Olsen, C. W.; Abbott, N. L., Anchoring of Nematic Liquid Crystals on Viruses with Different Envelope Structures. Nano Lett. 2006, 6 (5), 1053-1058. 9. Lockwood, N. A.; Gupta, J. K.; Abbott, N. L., Self-assembly of Amphiphiles, Polymers and Proteins at Interfaces between Thermotropic Liquid Crystals and Aqueous Phases. Surf Sci Rep 2008, 63 (6), 255-293. 10. Lockwood, N. A.; Mohr, J. C.; Ji, L.; Murphy, C. J.; Palecek, S. R.; de Pablo, J. J.; Abbott, N. L., Thermotropic Liquid Crystals as Substrates for Imaging the Reorganization of Matrigel by Human Embryonic Stem Cells. Adv. Funct. Mater. 2006, 16 (5), 618-624. 11. Price, A. D.; Schwartz, D. K., DNA Hybridization-Induced Reorientation of Liquid Crystal Anchoring at the Nematic Liquid Crystal/Aqueous Interface. J. Am. Chem. Soc. 2008, 130 (26), 8188-8194. 12. Shah, R. R.; Abbott, N. L., Principles for Measurement of Chemical Exposure based on RecognitionDriven Anchoring Transitions in Liquid Crystals. Science 2001, 293 (5533), 1296-1309. 13. Khan, M.; Park, S. Y., General Liquid-Crystal Droplets Produced by Microfluidics for Urea Detection. Sens. Actuator, B, 2014, 202, 516-522. 14. Kim, J.; Khan, M.; Park, S. Y., Glucose Sensor using Liquid-Crystal Droplets made by Microfluidics. ACS Appl. Mater. Interfaces 2013, 5 (24), 13135-13139. 15. Munir, S.; Khan, M.; Park, S. Y., Bienzyme Liquid-Crystal-based Cholesterol Biosensor. Sens. Actuator, B, 2015, 220, 508-515. 16. Meli, M. V.; Lin, I. H.; Abbott, N. L., Preparation of Microscopic and Planar Oil-Water Interfaces that are Decorated with Prescribed Densities of Insoluble Amphiphiles. J. Am. Chem. Soc. 2008, 130 (13), 43264333. 17. Price, A. D.; Schwartz, D. K., Fatty-Acid Monolayers at the Nematic/Water Interface: Phases and Liquid-Crystal alignment. J. Phys. Chem. B 2007, 111 (5), 1007-1015. 18. Brake, J. M.; Mezera, A. D.; Abbott, N. L., Effect of Surfactant Structure on the Orientation of Liquid Crystals at Aqueous−Liquid Crystal Interfaces†. Langmuir 2003, 19 (16), 6436-6442. 19. Gupta, J. K.; Abbott, N. L., Principles for Manipulation of the Lateral Organization of AqueousSoluble Surface-Active molecules at the Liquid Crystal-Aqueous Interface. Langmuir 2009, 25 (4), 2026-33. 20. Lockwood, N. A.; de Pablo, J. J.; Abbott, N. L., Influence of Surfactant Tail Branching and Organization on the Orientation of Liquid Crystals at Aqueous-Liquid Crystal Interfaces. Langmuir 2005, 21 (15), 6805-6814. 21. Brake, J. M.; Abbott, N. L., Coupling of the Orientations of Thermotropic Liquid Crystals to Protein Binding events at Lipid-Decorated Interfaces. Langmuir 2007, 23 (16), 8497-8507. 22. Park, J. S.; Abbott, N. L., Ordering Transitions in Thermotropic Liquid Crystals induced by the Interfacial Assembly and Enzymatic Processing of Oligopeptide Amphiphiles. Advan. Mater. 2008, 20 (6), 11851190. 23. Tercero Espinoza, L. A.; Schumann, K. R.; Luk, Y. Y.; Israel, B. A.; Abbott, N. L., Orientational Behavior of Thermotropic Liquid Crystals on Surfaces Presenting Electrostatically bound Vesicular Stomatitis


Page 14 of 17

Page 15 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Virus. Langmuir 2004, 20 (6), 2375-2385. 24. Bera, T.; Deng, J.; Fang, J., Protein-Induced Configuration Transitions of Polyelectrolyte-modified Liquid Crystal Droplets. J. Phys. Chem. B 2014, 118 (18), 4970-4975. 25. Jung, Y.-D.; Khan, M.; Park, S.-Y., Fabrication of temperature- and pH-sensitive liquid-crystal droplets with PNIPAM-b-LCP and SDS coatings by microfluidics. J. Mater. Chem. B 2014, 2 (30), 4922-4928. 26. Khan, M.; Kim, Y.; Lee, J. H.; Kang, I.-K.; Park, S.-Y., Real-Time Liquid Crystal-Based Biosensor for Urea Detection. Anal. Methods 2014, 6 (15), 5753-5759. 27. Khan, M.; Park, S. Y., Liquid Crystal-Based Proton Sensitive Glucose Biosensor. Anal. Chem. 2014, 86 (3), 1493-501. 28. Khan, M.; Park, S. Y., Liquid Crystal-Based Glucose Biosensor Functionalized with Mixed PAA And Qp4vp Brushes. Biosens. Bioelectron 2015, 68, 404-412. 29. Khan, M.; Park, S. Y., Specific Detection of Avidin-Biotin binding using Liquid Crystal Droplets. Colloid. Surface B 2015, 127, 241-246. 30. Lee, D. Y.; Seo, J. M.; Khan, W.; Kornfield, J. A.; Kurji, Z.; Park, S. Y., PH-Responsive Aqueous/LC Interfaces using SGLCP-b-Polyacrylic Acid block Copolymers. Soft Matter 2010, 6 (9), 1964-1970. 31. Seo, J. M.; Khan, W.; Park, S. Y., Protein Detection using Aqueous/LC Interfaces decorated with a novel Polyacrylic acid block Liquid Crystalline polymer. Soft Matter 2012, 8 (1), 198-203. 32. Chambers, R. C.; Bell, E. J.; Records, T. M.; Cherian, A.; Ragan, K.; Swartout, B., Cholesteric Liquid Crystal Displays as Optical Sensors of Barbiturate Binding. Liq. Cryst 2007, 34 (10), 1221-1226. 33. Collings, P. J.; Gray, G. W.; Goodby, J. W.; Hird, M., Introduction to Liquid Crystals: Chemistry and physics. Taylor & Francis: London, 1997. 34. Eelkema, R.; Pollard, M. M.; Katsonis, N.; Vicario, J.; Broer, D. J.; Feringa, B. L., Rotational Reorganization of Doped Cholesteric Liquid Crystalline Films. J. Am. Chem. Soc 2006, 128 (44), 14397-14407. 35. Eelkema, R.; Pollard, M. M.; Vicario, J.; Katsonis, N.; Ramon, B. S.; Bastiaansen, C. W.; Broer, D. J.; Feringa, B. L., Molecular Machines: Nanomotor Rotates Microscale Objects. Nature 2006, 440 (7081), 163. 36. Ichimura, K., Photoalignment of Liquid-Crystal Systems. Chem.Rev 2000, 100 (5), 1847-1874. 37. Iketa, T.; Feringa, B. L.; Kanazawa, A., Molecular Switches. Wiley-VCH: Weinheim: Germany, 2001. 38. Kirchner, N.; Zedler, L.; Mayerhofer, T. G.; Mohr, G. J., Functional Liquid Crystal films Selectively Recognize Amine Vapours and Simultaneously Change their Colour. Chem. Commun 2006, (14), 1512-1514. 39. Li, Q.; Green, L.; Venkataraman, N.; Shiyanovskaya, I.; Khan, A.; Urbas, A.; Doane, J. W., Reversible photoswitchable axially chiral dopants with high helical twisting power. J Am Chem Soc 2007, 129 (43), 129089. 40. Pieraccini, S.; Masiero, S.; Spada, G. P.; Gottarelli, G., A new Axially-Chiral Photochemical Switch. Chem Commun (Camb) 2003, (5), 598-9. 41. Shinkai, S.; Murata, K., Cholesterol-based functional tectons as versatile building-blocks for liquid crystals, organic gels and monolayers. J. Mater. Chem 1998, 8 (3), 485-495. 42. Tamaoki, N., Cholesteric Liquid Crystals for Color Information Technology. Advanc. Mater. 2001, 13 (15), 1135-1148 43. Winterbottom, D. A.; Narayanaswamy, R.; Raimundo, I. M., Cholesteric Liquid Crystals for Detection of Organic Vapours. Sens. Actuators, B 2003, 90 (1-3), 52-57. 44. Pieraccini, S.; Ferrarini, A.; Spada, G. P., Chiral Doping of Nematic Phases and its Application to the Determination of Absolute Configuration. Chirality 2008, 20 (5), 749-59. 45. Solladié, G.; Zimmermann, R. G., Liquid Crystals: A Tool for Studies on Chirality. Angew. Chem., Int. Ed. Engl. 1984, 23 (5), 348-362. 46. Eelkema, R.; Feringa, B. L., Amplification of Chirality in Liquid Crystals. Org Biomol Chem 2006, 4 (20), 3729-45. 47. Lee, S.; Su, K. K.; Reconfigurable Photonic Capsules Containing Cholesteric Liquid Crystals with Planar Alignment. Angew. Chem. 2015, 54(50), 15266-15270. 48. Zhong, S.; Jang, C. H., Nematic Liquid Crystals Confined in Microcapillaries for Imaging Phenomena at Liquid-Liquid Interfaces. Soft Matter 2015, 11 (35), 6999-7004. 49. Bezic, J.; Zumer, S., structures of the Cholesteric Liquid-Crystal Droplets with Parallel Surface Anchoring. Liq Cryst 1992, 11 (4), 593-619. 50. Humar, M.; Ravnik, M.; Pajk, S.; Musevic, I., Electrically Tunable Liquid Crystal Optical Microresonators. Nat Photonics 2009, 3 (10), 595-600. 51. Xu, F.; Crooker, P. P., Chiral Nematic Droplets with Parallel Surface Anchoring. Phys Rev E 1997, 56 (6), 6853-6860. 52. Cipparrone, G.; Mazzulla, A.; Pane, A.; Hernandez, R. J.; Bartolino, R., Chiral Self-Assembled Solid Microspheres: A Novel Multifunctional Microphotonic Device. Adv Mater 2011, 23 (48), 5773-5778. 53. Khan, W.; Choi, J. H.; Kim, G. M.; Park, S. Y., Microfluidic Formation of pH Responsive 5CB Droplets Decorated w ith PAA-b-LCP Lab Chip 2011, 11 (20), 3493-3498.



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

54. Khan, W.; Park, S. Y., Configuration Change of Liquid Crystal Microdroplets Coated with A Novel Polyacrylic Acid block Liquid Crystalline Polymer by Protein Adsorption. Lab Chip 2012, 12 (21), 4553-4559. 55. Kinsinger, M. L.; Sun, B.; Abbott, N. L.; Lynn, D. M., Reversible Control of Ordering Transitions at Aqueous/Liquid Crystal Interfaces using Functional Amphiphilic Polymers. Adv. Mater. 2007, 19 (23), 42084212 56. Liang, H. L.; Zentel, R.; Rudquist, P.; Lagerwall, J., Towards Tunable Defect Arrangements in Smectic Liquid Crystal Shells Utilizing the Nematic-Smectic Transition in Hybrid-Aligned Geometries. Soft Matter 2012, 8 (20), 5443-5450. 57. Bera, T.; Fang, J., Interaction of Surfactants and Polyelectrolyte-Coated Liquid Crystal Droplets. J. Mater. Sci. Chem. Eng. 2014, 02 (11), 1-7. 58. Omer, M.; Park, S. Y., Preparation of QP4VP-b-LCP Liquid Crystal block Copolymer and its Application as a biosensor. Anal Bioanal Chem 2014, 406 (22), 5369-5378. 59. Ko, S. W.; Huang, S. H.; Fuh, A. Y.; Lin, T. H., Measurement of Helical Twisting Power based on Axially Symmetrical Photo-Aligned Dye-Doped Liquid Crystal Film. Opt Express 2009, 17 (18), 15926-15931. 60. Orlova, T.; Asshoff, S. J.; Yamaguchi, T.; Katsonis, N.; Brasselet, E., Creation and Manipulation of Topological States in Chiral Nematic Microspheres. Nat Commun 2015, 6, 7603-7612. 61. Fan, J.; Li, Y.; Bisoyi, H. K.; Zola, R. S.; Yang, D.-k.; Bunning, T. J.; Weitz, D. A.; Li, Q., LightDirecting Omnidirectional Circularly Polarized Reflection from Liquid-Crystal Droplets. Angew. Chem. 2015, 127 (7), 2188-2192. 62. Noh, J.; Liang, H.-L.; Drevensek-Olenik, I.; Lagerwall, J. P. F., Tuneable Multicoloured Patterns from Photonic Cross-Communication between Cholesteric Liquid Crystal Droplets. J. Mater. Chem. C 2014, 2 (5), 806-810. 63. Wei, Y.; Jang, C. H., Detection of Cholesterol Molecules with A Liquid Crystal-Based pH-Driven Sensor. J Mater Sci 2015, 50 (13), 4741-4748.


Page 16 of 17

Page 17 of 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Table of Content Graphic

a

b


c

Cholesteric Liquid Crystal Droplets for Biosensors - ACS Applied

Recommend Documents